Metropolitan Life Insurance Company (MetLife)’s Insulet PODD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,816
| Closed | -$483K | – | 1582 |
|
|
2024
Q1 | $483K | Sell |
2,816
-26
| -0.9% | -$4.85K | 0.02% | 481 |
|
|
2023
Q4 | $617K | Sell |
2,842
-47
| -2% | -$8.06K | 0.03% | 429 |
|
|
2023
Q3 | $461K | Sell |
2,889
-149
| -5% | -$33.4K | 0.02% | 456 |
|
|
2023
Q2 | $876K | Sell |
3,038
-69
| -2% | -$21K | 0.04% | 348 |
|
|
2023
Q1 | $991K | Buy |
+3,107
| New | +$921K | 0.05% | 321 |
|
|
2022
Q1 | – | Sell |
-4,399
| Closed | -$1.17M | – | 2579 |
|
|
2021
Q4 | $1.17M | Sell |
4,399
-35
| -0.8% | -$10.2K | 0.02% | 862 |
|
|
2021
Q3 | $1.26M | Sell |
4,434
-145
| -3% | -$41.4K | 0.02% | 801 |
|
|
2021
Q2 | $1.26M | Sell |
4,579
-189
| -4% | -$51.4K | 0.02% | 840 |
|
|
2021
Q1 | $1.24M | Sell |
4,768
-215
| -4% | -$57.6K | 0.02% | 793 |
|
|
2020
Q4 | $1.27M | Sell |
4,983
-97
| -2% | -$24.1K | 0.02% | 730 |
|
|
2020
Q3 | $1.2M | Buy |
5,080
+72
| +1% | +$15.2K | 0.02% | 634 |
|
|
2020
Q2 | $973K | Buy |
5,008
+847
| +20% | +$162K | 0.02% | 756 |
|
|
2020
Q1 | $689K | Sell |
4,161
-131
| -3% | -$23.9K | 0.01% | 871 |
|
|
2019
Q4 | $735K | Sell |
4,292
-80
| -2% | -$13.3K | 0.01% | 1097 |
|
|
2019
Q3 | $721K | Buy |
4,372
+68
| +2% | +$9.56K | 0.01% | 1062 |
|
|
2019
Q2 | $514K | Sell |
4,304
-99
| -2% | -$10.2K | 0.01% | 1286 |
|
|
2019
Q1 | $419K | Sell |
4,403
-92
| -2% | -$7.88K | 0.01% | 1419 |
|
|
2018
Q4 | $357K | Sell |
4,495
-15
| -0.3% | -$1.27K | 0.01% | 1430 |
|
|
2018
Q3 | $478K | Sell |
4,510
-89
| -2% | -$8.33K | 0.01% | 1391 |
|
|
2018
Q2 | $394K | Sell |
4,599
-13,919
| -75% | -$1.25M | 0.01% | 1482 |
|
|
2018
Q1 | $1.61M | Buy |
18,518
+450
| +2% | +$35K | 0.02% | 669 |
|
|
2017
Q4 | $1.25M | Sell |
18,068
-21,524
| -54% | -$1.41M | 0.02% | 790 |
|
|
2017
Q3 | $2.18M | Sell |
39,592
-284
| -0.7% | -$15.5K | 0.01% | 912 |
|
|
2017
Q2 | $2.05M | Hold |
39,876
| – | – | 0.01% | 938 |
|
|
2017
Q1 | $1.72M | Sell |
39,876
-685
| -2% | -$29.4K | 0.01% | 1005 |
|
|
2016
Q4 | $1.53M | Hold |
40,561
| – | – | 0.01% | 1073 |
|
|
2016
Q3 | $1.66M | Sell |
40,561
-762
| -2% | -$30.1K | 0.01% | 1023 |
|
|
2016
Q2 | $1.25M | Buy |
41,323
+593
| +1% | +$18.4K | 0.01% | 1134 |
|
|
2016
Q1 | $1.35M | Buy |
40,730
+359
| +0.9% | +$11.3K | 0.01% | 1039 |
|
|
2015
Q4 | $1.53M | Sell |
40,371
-785
| -2% | -$26.4K | 0.01% | 994 |
|
|
2015
Q3 | $1.07M | Hold |
41,156
| – | – | 0.01% | 1155 |
|
|
2015
Q2 | $1.27M | Sell |
41,156
-2,114
| -5% | -$62.3K | 0.01% | 1144 |
|
|
2015
Q1 | $1.44M | Hold |
43,270
| – | – | 0.01% | 1023 |
|
|
2014
Q4 | $1.99M | Hold |
43,270
| – | – | 0.01% | 975 |
|
|
2014
Q3 | $1.59M | Hold |
43,270
| – | – | 0.01% | 1029 |
|
|
2014
Q2 | $1.72M | Hold |
43,270
| – | – | 0.01% | 1057 |
|
|
2014
Q1 | $2.05M | Hold |
43,270
| – | – | 0.01% | 970 |
|
|
2013
Q4 | $1.6M | Hold |
43,270
| – | – | 0.01% | 1073 |
|
|
2013
Q3 | $1.57M | Hold |
43,270
| – | – | 0.01% | 1053 |
|
|
2013
Q2 | $1.36M | Buy |
+43,270
| New | +$1.23M | 0.01% | 1085 |
|
Other funds holding PODD
Metropolitan Life Insurance Company (MetLife)'s PODD Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Insulet (PODD) in Q2 2024, closing a stake of 2,816 shares — an estimated $483K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in PODD in Q2 2013 and held it in 40 quarters. The position peaked at $2.18M in Q3 2017. 599 funds tracked by Wall St. Rank hold PODD as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Insulet position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 2,816 Insulet shares in Q2 2024, an estimated $483K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Insulet in Q2 2013 and held it in 40 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Insulet position peaked at $2.18M in Q3 2017.
- 599 funds tracked by Wall St. Rank held Insulet as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.